QIM
WST icon

Quest Investment Management’s West Pharmaceutical WST Stock Holding History

Quest Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,709
Closed -$3.52M – 133
2025
Q1 		$3.52M Buy
15,709
+12,056
+330% +$3.32M 0.44% 46
2024
Q4 		$1.2M Buy
+3,653
New +$1.15M 0.14% 64
2019
Q4 		– Sell
-26,346
Closed -$3.74M – 111
2019
Q3 		$3.74M Sell
26,346
-850
-3% -$117K 0.47% 52
2019
Q2 		$3.4M Sell
27,196
-2,779
-9% -$328K 0.42% 52
2019
Q1 		$3.3M Buy
29,975
+5,157
+21% +$536K 0.43% 51
2018
Q4 		$2.43M Buy
24,818
+2,232
+10% +$242K 0.38% 52
2018
Q3 		$2.79M Sell
22,586
-3,131
-12% -$351K 0.39% 54
2018
Q2 		$2.55M Sell
25,717
-2,599
-9% -$239K 0.38% 57
2018
Q1 		$2.5M Buy
28,316
+609
+2% +$57K 0.38% 60
2017
Q4 		$2.73M Buy
+27,707
New +$2.72M 0.4% 53
2014
Q3 		– Sell
-8,590
Closed -$362K – 233
2014
Q2 		$362K Sell
8,590
-3,340
-28% -$143K 0.04% 166
2014
Q1 		$526K Buy
11,930
+865
+8% +$40.7K 0.05% 128
2013
Q4 		$543K Buy
+11,065
New +$518K 0.05% 125

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Quest Investment Management's WST Position: Q2 2025 in Review

Quest Investment Management sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 15,709 shares — an estimated $3.52M sold.

Quest Investment Management first reported a position in WST in Q4 2013 and held it in 13 quarters. The position peaked at $3.74M in Q3 2019. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • Quest Investment Management reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Quest Investment Management sold 15,709 West Pharmaceutical shares in Q2 2025, an estimated $3.52M.
  • Quest Investment Management first reported a position in West Pharmaceutical in Q4 2013 and held it in 13 quarters.
  • Quest Investment Management's West Pharmaceutical position peaked at $3.74M in Q3 2019.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Quest Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.